{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:11:57Z","timestamp":1763017917174},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess trends in use of long-acting opioids during delivery hospitalizations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>The Perspective database, an administrative inpatient database that includes medication receipt, was analyzed to evaluate patterns of long-acting opioid use during delivery hospitalizations from January 2006 through March 2015. Medications evaluated included methadone, formulations including buprenorphine and extended-release formulations of oxycodone, morphine, fentanyl, and other opioids. Temporal trends in use of these medications were determined. Unadjusted and adjusted models evaluating the role of demographic and hospital factors were created evaluating both use of these medications and risk for severe morbidity. Risk for severe morbidity was determined based on Centers for Disease Control and Prevention criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Our analysis included 2,994,630 delivery hospitalizations meeting study criteria. Over the entire study period, use of long-acting opioids increased significantly from 457 to 844 per 100,000 deliveries. Although buprenorphine and methadone use increased, use of other long-acting opioids decreased. In 2006, methadone and buprenorphine accounted for less than one third of all long-acting opioids used during delivery hospitalizations. By 2015, buprenorphine and methadone represented 73.5% of long-acting opioids used. In adjusted and unadjusted models, risk for severe morbidity was significantly lower with buprenorphine or methadone compared with other long-acting opioids. Restricting the cohort to only women with drug abuse or dependence, risk for severe morbidity was lower with methadone and buprenorphine than without any long-acting opioids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Increased use of methadone and buprenorphine in this study supports the feasibility of use of these medications during pregnancy and uptake of clinical recommendations for women with opioid use disorder. Use of methadone and buprenorphine is associated with decreased maternal morbidity, although causation cannot be presumed from this study model.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002861","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:27:44Z","timestamp":1537993664000},"page":"937-947","source":"Crossref","is-referenced-by-count":17,"title":["Trends and Outcomes Associated With Using Long-Acting Opioids During Delivery Hospitalizations"],"prefix":"10.1097","volume":"132","author":[{"given":"Cassandra R.","family":"Duffy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella J.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina R.","family":"Kern-Goldberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"D\u2019Alton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2011.401","article-title":"Characteristics of opioid prescriptions in 2009","volume":"305","author":"Volkow","year":"2011","journal-title":"JAMA"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among Medicaid-enrolled women","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","first-page":"249","article-title":"Opioid prescriptions soar: increase in legitimate use as well as abuse","volume":"297","author":"Kuehn","year":"2007","journal-title":"JAMA"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamainternmed.2014.8071","article-title":"Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy","volume":"175","author":"Miller","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/ALN.0000000000000172","article-title":"Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States","volume":"120","author":"Bateman","year":"2014","journal-title":"Anesthesiology"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1538-7836.2011.04326.x","article-title":"Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery","volume":"9","author":"Fang","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCINTERVENTIONS.112.968313","article-title":"Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery","volume":"5","author":"Kulik","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/STROKEAHA.114.008006","article-title":"Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?","volume":"46","author":"Prabhakaran","year":"2015","journal-title":"Stroke"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/AOG.0b013e31821bdd16","article-title":"Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy","volume":"117","author":"Ritch","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/SLA.0b013e31821287ac","article-title":"Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery","volume":"253","author":"Wright","year":"2011","journal-title":"Ann Surg"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1227\/NEU.0000000000001270","article-title":"Quality of postoperative venous thromboembolism prophylaxis in neuro-oncologic surgery","volume":"80","author":"Zacharia","year":"2017","journal-title":"Neurosurgery"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.2010.841","article-title":"Adherence to surgical care improvement project measures and the association with postoperative infections","volume":"303","author":"Stulberg","year":"2010","journal-title":"JAMA"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","article-title":"An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity","volume":"12","author":"Kuklina","year":"2008","journal-title":"Matern Child Health J"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","article-title":"False alarms and pseudo-epidemics: the limitations of observational epidemiology","volume":"120","author":"Grimes","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/1471-0528.13254","article-title":"Validation of an obstetric comorbidity index in an external population","volume":"122","author":"Metcalfe","year":"2015","journal-title":"BJOG"},{"issue":"suppl 1","key":"R22-20230711","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:17:50Z","timestamp":1689103070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002861","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}